According to a group of researchers on the University of Houston College of Pharmacy, manipulating TAK1, a key signaling protein concerned within the construction...
Picture this: you’re sitting in a traditional Japanese teahouse, surrounded by the vibrant colours and flavours of a bountiful feast. You take a bite...
Texas-based Reata Pharmaceuticals has introduced that it'll discontinue the development of its chronic kidney disease drug, bardoxolone, after research confirmed little long-term...
